This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Sep;103(9):1744-1745.

doi: 10.1097/TP.0000000000002754.

Hypoimmunogenic Genetically Modified Induced Pluripotent Stem Cells for Tissue Regeneration

Sabrina Wright¹, Fadi Issa

Affiliations

PMID: 30985582
DOI: 10.1097/TP.0000000000002754

Editorial

Hypoimmunogenic Genetically Modified Induced Pluripotent Stem Cells for Tissue Regeneration

Sabrina Wright et al. Transplantation. 2019 Sep.

. 2019 Sep;103(9):1744-1745.

doi: 10.1097/TP.0000000000002754.

Authors

Sabrina Wright¹, Fadi Issa

Affiliation

¹ 1 Transplantation Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.

PMID: 30985582
DOI: 10.1097/TP.0000000000002754

No abstract available

PubMed Disclaimer

Comment on

Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
Deuse T, Hu X, Gravina A, Wang D, Tediashvili G, De C, Thayer WO, Wahl A, Garcia JV, Reichenspurner H, Davis MM, Lanier LL, Schrepfer S. Deuse T, et al. Nat Biotechnol. 2019 Mar;37(3):252-258. doi: 10.1038/s41587-019-0016-3. Epub 2019 Feb 18. Nat Biotechnol. 2019. PMID: 30778232 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Grants and funding

211122/Z/18/Z/WT_/Wellcome Trust/United Kingdom

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer